NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kapoose Creek Bio

Kapoose Creek Bio

Private
VancouverHealthcare & Life Scienceshttps://kapoosecreek.com/

Last Round

Grant

Nov 21, 2025

Total Funding Raised

$7M

Company Overview

Kapoose Creek Bio is a biotechnology company that develops AI-driven drug discovery platforms to identify small-molecule therapeutics from natural sources.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryai drug discoverysmall molecule therapeuticsmultiomicsfungal libraryphenotypic screeningbiotechin silico drug discoverychemical informaticslead optimizationdrug developmentnatural product discoveryai biotechtherapeutic pipelinedrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kapoose Creek Bio Comps

Public and private peers based on sector, stage, and business model.

Kapoose Creek Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kapoose Creek Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 21, 2025
DebtMay 30, 2024
GrantMay 30, 2024

Key People

Founding team and executive leadership

Eric Brown

Chief Executive Officer

Executive Team

Jonathan Jackson CPA CA ICD.D

Chief Financial Officer

Executive Team

Kapoose Creek Bio Investors

Notable investors and investment history

Kapoose Creek Bio investors
InvestorRounds
Innovation FactoryGrant
MitacsGrant
Genome CanadaGrant
McMaster UniversityGrant
Ontario GenomicsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 19, 2024

    Monthly visitors increased 125% MoM, reaching 971.

  • May 30, 2024

    $2.3M grant received from Genome Canada and others.

Kapoose Creek Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kapoose Creek Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kapoose Creek Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range13
Year Founded2020
Last FundingNov 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.